MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Early Impairment in the Immunomodulatory Function of Mesenchymal Stromal Cells Contributes to Heightened Peripheral and Neuroinflammation in Parkinson’s Disease Insights From In Vivo Chronic PD Rat Model and In Vitro PD iPSC Model

    R. Ghanty, I. Datta, G. Wagmare, N. Kamble, PK. Pal, V. Holla, R. Yadav, K. Mondal (Bengaluru, India)

    Objective: To assess the timeline dependent changes in endogenous Bone-Marrow-Mesenchymal-Stromal-Cells (BMMSC) in in-vivo chronic PD model and validating these cellular modifications in human iPSC derived…
  • 2025 International Congress

    The Bjorn Moller Research Repository: A Resource for Movement Disorders Research

    S. Schaffner, A. Kuan, D. Felix, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To build a repository of longitudinally collected biological samples and clinical, demographic, and lifestyle data from individuals with Parkinson’s disease (PD) and other movement…
  • 2025 International Congress

    Brain Energetics: Changes in Healthy Aging and Parkinson’s Disease

    C. Bevington, S. Dhaliwal, J. Mckenzie, A. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: To identify in vivo bioenergetic alterations in healthy aging and Parkinson’s disease (PD). Background: PD-related cerebral metabolic alterations have been robustly characterized [1] and…
  • 2025 International Congress

    Influence of Gut Microbiota-Derived TMAO on Disease Severity in Parkinson’s Disease

    S. Virameteekul (Bangkok, Thailand)

    Objective: This study aims to investigate how gut microbiota composition influences trimethylamine N-oxide (TMAO) levels in PD patients and whether TMAO and gut microbiota composition…
  • 2025 International Congress

    Comparison of MIBG Uptake in the Major Salivary Glands Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease

    J. Ebina, S. Mizumura, M. Shibukawa, J. Nagasawa, T. Hirayama, N. Ishii, Y. Kobayashi, A. Inaba, S. Orimo, O. Kano (Tokyo, Japan)

    Objective: This study aimed to evaluate 123I-metaiodobenzylguanidine (MIBG) uptake in the major salivary glands (MSG) in patients with rapid eye movement sleep behavior disorder (RBD)…
  • 2025 International Congress

    Longitudinal MRI Study of Hippocampal Subfields Morphometry in Early Parkinson’s Disease

    T. Wu, S. Ng, T. Teo, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Chan, L. Tan, T. Welton (Singapore, Singapore)

    Objective: This prospective cohort study longitudinally investigated hippocampal subfield shape deformation and atrophy in early-stage Parkinson’s Disease (PD), using spherical harmonic-based shape analysis. Background: Hippocampal…
  • 2025 International Congress

    Impact of Patient-Specific Structural Connectivity of STN-DBS on Balance and Mobility – Pilot study

    š. Janovič, S. Holly, M. Chmelík, D. Juskanič, L. Pátrovič, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

    Objective: To evaluate the impact of patient-specific structural connectivity between VTA in STN targeting and SMA/preSMA on functional mobility improvements in PD patients undergoing DBS.…
  • 2025 International Congress

    Description Genotype/phenotype of patients with Parkinson’s disease. Report of an Argentinean cohort included in the LARGE PD Consortium.

    M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, J. Etcheverry, I. Mata, C. Perandones, E. Gatto (Cleveland, USA)

    Objective: To characterize the genetic and phenotypic profile of Argentinean Parkinson's patients and contribute to the understanding of the genetic heterogeneity of this disease. Background:…
  • 2025 International Congress

    Assessing the potential association of rs2298383 in ADORA2A as a predictor of Levodopa-Induced Dyskinesia in Latin American Parkinson’s Disease patients

    HM. Chaparro-Solano, E. Waldo, T. Peixoto-Leal, AF. Schumacher-Schuh, BL. Santos-Lobato, E. Gatto, G. Arboleda, JL. Orozco-Velez, P. Chana-Cuevas, D. Aguillon, M. Rodriguez-Violante, D. Martinez-Ramirez, M. Cornejo-Olivas, A. Vinuela, G. Alvarado, P. Olguín, S. Alcauter, IF. Mata (Cleveland, USA)

    Objective: To analyze the association between ADORA2A-rs2298383 and levodopa induced dyskinesias (LID) in a cohort of Latin American Parkinson’s disease patients. Background: Previous evidence has…
  • 2025 International Congress

    Prevalence and Characteristics of Glucocerebrosidase Genetic Variants in Nepalese Early-onset Parkinson’s Disease Patients

    R. Ojha, B. Gajurel, N. Gautam, R. Karn, R. Rajbhandari, S. Shahi, V. Sharma, S. Baidya, A. Bhattarai, A. Niraula, E. Tuladhar, A. Adhikari, Y. Tay, S. Lim, A. Tan (Kathmandu, Nepal)

    Objective: To evaluate the genotype and phenotype of early-onset Parkinson´s Disease (EOPD) in the Nepalese population. Background: A significant proportion of early-onset PD (EOPD) can…
  • « Previous Page
  • 1
  • …
  • 177
  • 178
  • 179
  • 180
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley